Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping

Blood Transfusion

Volumn 10, Issue SUPPL. 2, 2012, Pages

  Marrocco, Cristina ^a   Pallotta, Valeria ^a   D'Alessandro, Angelo ^a   Alves, Gilda ^b   Zolla, Lello ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Blood doping; Peroxiredoxin 2; Population; Red blood cell

Indexed keywords

BIOLOGICAL MARKER; PEROXIREDOXIN 2; PEROXIREDOXIN;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DOPING; CELL SUBPOPULATION; DENSITY GRADIENT CENTRIFUGATION; DILUTION; ERYTHROCYTE SUBPOPULATION; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; STORAGE; WESTERN BLOTTING; CHEMISTRY; DOPING; ERYTHROCYTE; ERYTHROCYTE MEMBRANE;

ADULT; BIOLOGICAL MARKERS; DOPING IN SPORTS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; HUMANS; MALE; PEROXIREDOXINS;

EID: 84861784509     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.011S     Document Type: Article

References (29)

1. Segura J, Monfort N, Ventura R. Detection methods for autologous blood doping. Drug Test Anal 2012 doi: 10.1002/dta.405.
2. Lippi G, Banfi G. Blood transfusions in athletes. Old dogmas, new tricks. Clin Chem Lab Med 2006; 44(12): 1395-402. (Pubitemid 44967686)
3. Giraud S, Sottas PE, Robinson N, Saugy M. Blood transfusion in sports. Handb Exp Pharmacol 2010; (195): 295-304.
4. Ashenden M. A strategy to deter blood doping in sport. Haematologica 2002; 87: 225-34.
5. Baumann GP. Growth Hormone Doping in Sports: A Critical Review of Use and Detection Strategies. Endocr Rev 2012; doi: 10.1210/er.2011-1035.
6. Arndt PA, Kumpel BM. Blood doping in athletes - detection of allogeneic blood transfusions by flow cytofluorometry. Am J Hematol 2008; 83(8): 657-67.
7. D'Alessandro A, Liumbruno G, Grazzini G, Zolla L. Red blood cell storage: the story so far. Blood Transfus 2010 Apr; 8(2): 82-8.
8. D'Alessandro A, D'Amici GM, Vaglio S, Zolla L. Time-course investigation of SAGM-stored leukocyte-filtered red bood cell concentrates: from metabolism to proteomics. Haematologica 2012; 97(1): 107-15.
9. Pallotta V, D'Amici GM, D'Alessandro A, et al. Red blood cell processing for cryopreservation: from fresh blood to deglycerolization. Blood Cells Mol Dis 2012; doi: 10.1016/j.bcmd.2012.02.004
10. Eichner ER. Blood doping: infusions, erythropoietin and artificial blood. Sports Med 2007; 37(4-5): 389-91. (Pubitemid 46698547)
11. Tsitsimpikou C, Kouretas D, Tsarouhas K, et al. Applications and biomonitoring issues of recombinant erythropoietins for doping control. Ther Drug Monit. 2011; 33(1): 3-13.
12. Ashenden M, Mørkeberg J. Net haemoglobin increase from reinfusion of refrigerated vs. frozen red blood cells after autologous blood transfusions. Vox Sang 2011; 101(4): 320-6.
13. Solymos E, Guddat S, Geyer H, et al. Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. Drug Test Anal 2011; 3(11-12): 892-5.
14. Lion N, Crettaz D, Rubin O, Tissot JD. Stored red blood cells: a changing universe waiting for its map(s). J Proteomics 2010; 73(3): 374-85.
15. Blasi B, D'Alessandro A, Ramundo N, Zolla L. Red blood cell storage and cell morphology. Transfus Med 2012 Apr; 22(2): 90-6.
16. Bosman GJ, Werre JM, Willekens FL, Novotný VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18(6): 335-47.
17. Rinalducci S, D'Amici GM, Blasi B, et al. Peroxiredoxin-2 as a candidate biomarker to test oxidative stress levels of stored red blood cells under blood bank conditions. Transfusion 2011; 51(7): 1439-49.
18. Rinalducci S, D'Amici GM, Blasi B, Zolla L. Oxidative stress-dependent oligomeric status of erythrocyte peroxiredoxin II (PrdxII) during storage under standard blood banking conditions. Biochimie 2011; 93: 845-85.
19. Olivieri E, Herbert B, Righetti PG. The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. Electrophoresis 2001; 22(3): 560-5. (Pubitemid 32166581)
20. Low FM, Hampton MB, Peskin AV, Winterbourn CC. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 2007; 109(6): 2611-7. (Pubitemid 46425910)
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 Aug 15; 227(5259): 680-5.
22. Bosch FH, Werre JM, Roerdinkholder-Stoelwinder B, Huls TH, Willekens FL, Halie MR. Characteristics of red blood cell populations fractionated with a combination of counterflow centrifugation and Percoll separation. Blood. 1992; 79(1): 254-60.
23. Hess JR. An update on solutions for red cell storage. Vox Sanguinis 2006; 91: 13-9. (Pubitemid 43822299)
24. th edition). Recommendation No. R (95) 15. Strasbourg, France: European Directorate for the Quality of Medicines & HealthCare; 2011.
25. Valeri CR, Collins FB. Physiologic effects of 2,3-DPG-depleted red cells with high affinity for oxygen. J Appl Physiol 1971; 31: 823-7.
26. Rocha S, Vitorino RM, Lemos-Amado FM, et al. Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis 2008; 41(1): 5-9.
27. Eber SW, Pekrun A, Neufeldt A, Schröter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol 1992; 64: 88.
28. Pottgiesser T, Sottas PE, Echteler T, et al. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study. Transfusion 2011; 51(8): 1707-15.
29. D'Alessandro A, Blasi B, D'Amici GM et al. Red blood cell populations in freshly drawn blood: application of proteomics and metabolomics to a decades-long biological issue. Blood Transfusion 2012; DOI: 10.2450/2012.0164- 11.